Genetic studies utilizing whole-exome and gene expression analyses have identified mutations in four tumor driver genes—KRAS, TP53, SMAD4, and CDKN2A—as molecular fingerprints for PDAC, with KRAS being prevalent in nearly all cases of the disease [14,15,16,17,18,19]. The gene discussed is KRAS; the disease is neoplasm.